BioNote Stock

BioNote EBITDA Margin

The EBITDA Margin of BioNote (377740.KS) as of Aug 2, 2026 is 13.81 %. In the previous year, EBITDA Margin was -50.15 % — a change of -127.55% (higher).

EBITDA Margin

13.81 %

YoY

-127.55%

Last updated:

EBITDA Margin of BioNote is 2026 13.81 % . EBITDA Margin of BioNote was 2025 -50.15 % . It decreases by -127.55% higher compared to the previous year.
Access this data via the Eulerpool API

BioNote Stock analysis

What does BioNote do? BioNote is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNote stock

EBITDA Margin of BioNote is 13.81 % in 2026.

Access this data via the Eulerpool API

Margins — BioNote

All Key Metrics — BioNote